21 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated
S-3
EX-5.1
CGTX
Cognition Therapeutics Inc
23 Dec 22
Shelf registration
4:16pm
. In rendering this opinion and giving this consent, we do not admit that we are an “expert” within the meaning of the Securities Act.
Very truly yours,
Troutman Pepper Hamilton Sanders LLP
-5-
DEF 14A
larkue 6q
25 Apr 22
Definitive proxy
5:28pm
S-8
EX-5.1
c8zwgs
30 Mar 22
Registration of securities for employees
8:37am
8-K
bta5x9rafgrgp
3 Nov 21
Departure of Directors or Certain Officers
4:25pm
S-8
EX-5.1
mt0aia8 mydbr
2 Nov 21
Registration of securities for employees
4:51pm
8-K
EX-3.2
e2vh4j5ec
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
rn4nefs5u0x3z40i
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1/A
EX-10.1
59z0ve8s26s8jo
29 Jul 21
IPO registration (amended)
4:45pm
S-1/A
EX-3.8
3w4 6bamawkns
29 Jul 21
IPO registration (amended)
4:45pm
CORRESP
mahqr7v jzt8bfghyctd
29 Jul 21
Correspondence with SEC
12:00am
S-1
379b2soojwj66vktb
19 Jul 21
IPO registration
7:02am
DRS/A
qthrd8
23 Jun 21
Draft registration statement (amended)
12:00am